Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

CP-751,871 + carboplatin + paclitaxel

Chemotherapy (carboplatin and paclitaxel) and CP-751,871 (6, 10 or 20mg/kg) will be administered by intravenous infusion every three weeks.

Trial Locations (1)

Pfizer Investigational Site, Chuo-ku